Leveraging Fragment-Based Drug Discovery to Advance 3D Scaffolds into Potent Ligands: Application to the Histamine H 1 Receptor

Key Points

• The research aims to enhance fragment-based drug discovery by integrating 3D scaffolds early in the process to develop effective ligands for the histamine H1 receptor.
• Utilized fragment-based drug discovery techniques.
• Screened 2D aromatic fragments for initial hits.
• Developed 3D scaffolds and analyzed their effectiveness in binding to the histamine H1 receptor.
• Identified several potent ligands through the application of 3D scaffolds.
• Demonstrated improved binding affinity of 3D scaffolds compared to traditional 2D fragments.
• Showed potential for better therapeutic options targeting the histamine H1 receptor.